Abstract:Introduction: Prader-Willi syndrome (PWS) is a rare disease, which shows a peculiar clinical phenotype, including obesity, which is different from essential obesity (EOB). Metabolomics might represent a valuable tool to reveal the biochemical mechanisms/pathways underlying clinical differences between PWS and EOB. The aim of the present (case-control, retrospective) study was to determine the metabolomic profile that characterizes PWS compared to EOB. Methods: A validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) targeted metabolomic approach was used to measure a total of 188 endogenous metabolites in plasma samples of 32 patients with PWS (F/M = 23/9; age: 31.6 ± 9.2 years; body mass index [BMI]: 42.1 ± 7.0 kg/m 2 ), compared to a sex-, age- and BMI-matched group of patients with EOB (F/M = 23/9; age: 31.4 ± 6.9 years; BMI: 43.5 ± 3.5 kg/m 2 ). Results: Body composition in PWS was different when compared to EOB, with increased fat mass and decreased fat-free mass. Glycemia and HDL cholesterol were higher in patients with PWS than in those with EOB, while insulinemia was lower, as well as heart rate. Resting energy expenditure was lower in the group with PWS than in the one with EOB, a difference that was missed after fat-free mass correction. Carrying out a series of Tobit multivariable linear regressions, adjusted for sex, diastolic blood pressure, and C reactive protein, a total of 28 metabolites was found to be associated with PWS (vs. non-PWS, i.e., EOB), including 9 phosphatidylcholines (PCs) ae, 5 PCs aa, all PCs aa, 7 lysoPCs a, all lysoPCs, 4 acetylcarnitines, and 1 sphingomyelin, all of which were higher in PWS than EOB. Conclusions: PWS exhibits a specific metabolomic profile when compared to EOB, suggesting a different regulation of some biochemical pathways, fundamentally related to lipid metabolism.

Diet Therapy of Prader-Willi Syndrome: 4 Cases Report

Endocrine and metabolic features of female children with Prader-Willi syndrome: an analysis of 4 cases

Hypothalamic-pituitary-gland axis function changes and metabolic manifestations of children with Prader-Willi syndrome

Ketonuria in an adult with Prader-Willi syndrome and diabetes mellitus: A case report

Nutritional and metabolic findings in patients with Prader-Willi syndrome diagnosed in early infancy.

Recommendations for the Diagnosis and Management of Childhood Prader-Willi Syndrome in China

Clinical and Molecular Characterization of Prader-Willi Syndrome

Genetic Diagnosis and Weight Loss Surgery of a Case of Prader-Willi Syndrome

Neuromodulation for the treatment of Prader-Willi syndrome – A systematic review

Nutritional phases of Prader-Willi syndrome

Clinical and genetic analysis for four Chinese families with Prader–Willi syndrome

Do patients with Prader–Willi syndrome have favorable glucose metabolism?

Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation

Behavior Modification Maintenance with Long-Term Blood Glucose and Weight Management in Prader–Willi Syndrome Complicated with Diabetes: Team Management Approach Combined with Pharmacological Treatment

Prader-Willi Syndrome: guidance for children and transition into adulthood

Relationship of thyroid function with genetic subtypes and treatment with growth hormone in Prader–Willi syndrome

Insulin Sensitivity in a Patient with Prader-Willi Syndrome

Methods of Determining Energy Expenditure in Individuals with Prader-Willi Syndrome: A Systematic Literature Review

Metabolomic profiling of Prader-Willi syndrome compared with essential obesity

Autonomic nervous system dysfunction in Prader–Willi syndrome

Assessment of Body Composition Using Bioelectrical Impedance Analysis in Prader-Willi Syndrome.